Edward White
Stock Analyst at HC Wainwright & Co.
(1.85)
# 3,286
Out of 5,014 analysts
358
Total ratings
30.18%
Success rate
-7.62%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $6.45 | +411.63% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $11.03 | +54.13% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $6.10 | +145.90% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $2.34 | +156.41% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.62 | +887.65% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.66 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $11.48 | +596.86% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.55 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $3.00 | +566.67% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $6.40 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $4.82 | +231.95% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.09 | +310.51% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.47 | +444.22% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $14.22 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.93 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $35.75 | +53.85% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $16.50 | +209.09% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.23 | +33.84% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $5.90 | +849.15% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $10.18 | +204.52% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.02 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $9.44 | +7,315.25% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $26.84 | +11.77% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.51 | +694.70% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $6.45
Upside: +411.63%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $11.03
Upside: +54.13%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $6.10
Upside: +145.90%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $2.34
Upside: +156.41%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.62
Upside: +887.65%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.66
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $11.48
Upside: +596.86%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.55
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $3.00
Upside: +566.67%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $6.40
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $4.82
Upside: +231.95%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.09
Upside: +310.51%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.47
Upside: +444.22%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $14.22
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.93
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $35.75
Upside: +53.85%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $16.50
Upside: +209.09%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $5.23
Upside: +33.84%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $5.90
Upside: +849.15%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $10.18
Upside: +204.52%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.02
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $9.44
Upside: +7,315.25%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $26.84
Upside: +11.77%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.51
Upside: +694.70%